Position in ABSI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,885,934
+$9,815,710 QoQ
Shares Held
1,111,815
+8.6% QoQ
Ownership
0.648%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 195 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. ABSI ranks #103 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ABSI
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,885,934 | 1,111,815 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $3,070,224 | 1,023,408 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,450,921 | 988,803 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $3,142,532 | 1,033,728 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,099,690 | 817,001 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,665,034 | 663,361 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,717,825 | 655,659 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $2,419,858 | 633,471 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $569,578 | 184,928 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $717,974 | 126,404 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $528,956 | 125,942 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $136,691 | 103,554 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $140,773 | 92,614 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $722,684 | 412,963 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $893,203 | 425,335 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,337,429 | 427,294 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,248,449 | 376,039 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,381,896 | 401,174 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,016,750 | 123,994 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,422,011 | 122,271 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||